Trial Profile
Study on the effect of rituximab for steroid-dependent nephrotic syndrome
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Nephrotic syndrome
- Focus Therapeutic Use
- 12 May 2015 New trial record